Soc. Generale Call 42.76 OMV 20.0.../ DE000SU13UX8 /
9/25/2024 9:46:34 PM | Chg.-0.020 | Bid9/25/2024 | Ask9/25/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.110EUR | -15.38% | 0.110 Bid Size: 10,000 |
0.120 Ask Size: 10,000 |
OMV AG | 42.76 EUR | 6/20/2025 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center